首页> 美国卫生研究院文献>Proceedings of the National Academy of Sciences of the United States of America >Long antibody HCDR3s from HIV-naïve donors presented on a PG9 neutralizing antibody background mediate HIV neutralization
【2h】

Long antibody HCDR3s from HIV-naïve donors presented on a PG9 neutralizing antibody background mediate HIV neutralization

机译:在PG9中和抗体背景上呈示的来自未使用HIV的供体的长抗体HCDR3介导了HIV中和

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Development of broadly neutralizing antibodies (bnAbs) against HIV-1 usually requires prolonged infection and induction of Abs with unusual features, such as long heavy-chain complementarity-determining region 3 (HCDR3) loops. Here we sought to determine whether the repertoires of HIV-1–naïve individuals contain Abs with long HCDR3 loops that could mediate HIV-1 neutralization. We interrogated at massive scale the structural properties of long Ab HCDR3 loops in HIV-1–naïve donors, searching for structured HCDR3s similar to those of the HIV-1 bnAb PG9. We determined the nucleotide sequences encoding 2.3 × 107 unique HCDR3 amino acid regions from 70 different HIV-1–naïve donors. Of the 26,917 HCDR3 loops with 30-amino acid length identified, we tested 30 for further study that were predicted to have PG9-like structure when chimerized onto PG9. Three of these 30 PG9 chimeras bound to the HIV-1 gp120 monomer, and two were neutralizing. In addition, we found 14 naturally occurring HCDR3 sequences that acquired the ability to bind to the HIV-1 gp120 monomer when adding 2- to 7-amino acid mutations via computational design. Of those 14 designed Abs, 8 neutralized HIV-1, with IC50 values ranging from 0.7 to 98 µg/mL. These data suggest that the repertoire of HIV-1–naïve individuals contains rare B cells that encode HCDR3 loops that bind or neutralize HIV-1 when presented on a PG9 background with relatively few or no additional mutations. Long HCDR3 sequences are present in the HIV-naïve B-cell repertoire, suggesting that this class of bnAbs is a favorable target for rationally designed preventative vaccine efforts.
机译:研发针对HIV-1的广泛中和抗体(bnAbs)通常需要长时间感染和诱导具有异常特征(例如长的重链互补决定区3(HCDR3)环)的Abs。在这里,我们试图确定未感染过HIV-1的个体的库中是否含有可介导HIV-1中和的长HCDR3环的Abs。我们大规模研究了未经HIV-1感染的供体中长Ab HCDR3环的结构特性,寻找与HIV-1 bnAb PG9相似的结构化HCDR3。我们确定了编码自70个不同的HIV-1初次供体的2.3×10 7 独特HCDR3氨基酸区域的核苷酸序列。在鉴定出的具有30个氨基酸长度的26,917个HCDR3环中,我们测试了30个用于进一步研究,这些研究被预测与PG9嵌合时具有PG9样结构。这30个PG9嵌合体中有3个与HIV-1 gp120单体结合,有2个被中和。此外,我们发现了14个天然存在的HCDR3序列,通过计算设计添加2至7个氨基酸突变后,它们具有与HIV-1 gp120单体结合的能力。在这14种设计的抗体中,有8种中和了HIV-1,IC50值在0.7至98 µg / mL之间。这些数据表明,纯朴的HIV-1个体的库中含有罕见的B细胞,这些细胞编码HCDR3环,当在PG9背景上以相对较少或没有其他突变的形式结合或中和HIV-1。在未感染HIV的B细胞库中存在长HCDR3序列,这表明这类bnAb是合理设计预防性疫苗工作的有利靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号